Cardiovascular Diseases (CVD) Marker Tests Market Projected To Grow With Significant CAGR Over The Forecast Period

28/mag/2018 14:38:28 PBIGP Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Cardiovascular Diseases (CVD) Marker Tests Market Projected To Grow With Significant CAGR Over The Forecast Period

 

Congestive heart disease is a type of cardiovascular diseases. Congestive heart disease marker tests are diagnostic tests to measure the concentration of the protein to identify the occurrence and disease phase. Cardiac biomarkers evaluate the cardiac function and help in identifying the severity and complexity of procedures to treat CVD. The most commonly used cardiac biomarkers for diagnosis of CVD include troponin I and T, CK-MB, BNPs, myoglobin, and IMA, among others.

 

Increase in geriatric population, rise in funding from private-public organizations for cardiac biomarkers research, and ongoing research and clinical trials for identification of the newer cardiac biomarkers are the key factors that will boost the congestive heart disease marker tests market. However, technical problems such as sample collection and storage, stringent regulatory guidelines, lack of reimbursement systems can hamper the market growth of cardiac marker tests market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-disease-marker-tests-market/#ulp-4H8Z4LpNMLEuOnnx

 

The congestive heart disease marker tests market is categorized as under-

1.      Product type

·         Reagents

·         Kits

·         Instruments

·         Chemiluminescence

·         Immunofluorescence

·         ELISA

·         Immunochromatography

2.     Test type

·         Myocardial muscle Creatine Kinase (CK-MB)

·         Myoglobin

·         Troponins (T and I)

·         Ischemia Modified Albumin (IMA)

·         NT-proBNP or Brain Natriuretic Peptide (BNP) or

·         Others

3.     Applications

·         Myocardial Infarction

·         Acute Coronary Syndrome

·         Congestive Heart Failure

·         Atherosclerosis

·         Others

4.     End-users

Hospitals, Clinics and diagnostic Centers.

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-disease-marker-tests-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions division, the congestive heart disease marker tests market has five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is the major contributor owing to increasing numbers of congestive heart failures, aging population, increase in inclination toward point-of-care testing, and elevated frequency of cardiovascular disorders are the key factors leading the growth of the congestive heart disease marker tests market. Following the footsteps is Europe region, which holds a major share in global congestive heart disease marker tests market attributed to increase in the numbers of congestive heart failure, increased R & D activities, etc. The Asia-Pacific is expected to exhibit significant growth due to increase in prevalence of Myocardial Infarction, public–private initiatives to increase the awareness related to early cardiac disease diagnosis in physicians and patients.

 

Some of the key players in congestive heart disease marker test market are F. Hoffmann-La Roche (Switzerland), Siemens AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Nanogen, Inc. (U.S.), bioMérieux SA (France), Alere, Inc. (U.S.),  LSI Medience Corporation (Mitsubishi Chemical Holdings Corporation, Japan), Randox Laboratories Ltd (U.K.), Ortho Clinical Diagnostics (The Carlyle Group) (U.S.),and Guangzhou Wondfo Biotech Co. Ltd. (China) to name a few. The National Institute for Health and Care Excellence, in 2016, developed a Medtech Innovation Briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-disease-marker-tests-market/#ulp-14mlyhjMGhVjZqa3

 

 

Launch of new products, technological advancements, acquisitions and mergers, and collaborations are some key strategies followed by various industry players to increase their share in the congestive heart disease marker test market.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-disease-marker-tests-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl